BICO Group AB’s board has elected Maria Rankka as chair until a new chair is named at the company’s shareholders’ meeting. She succeeds Rolf Classon who has resigned for health reasons. Ms Ranke, an investor and entrepreneur mainly in health tech and life science, joined BICO’s board in May. She is also board chair of a Swedish stem cells company Cellcolabs.
Her new position at BICO supports the Swedish company’s focus on its BICO 2.0 strategy commercially and in communications. BICO supports pharma companies, biopharma and academia to bring innovations to market by automating life science laboratories through hardware and software.
BICO Group announced the appointment on 16 September 2025.
Copyright 2025 Evernow Publishing Ltd.